In the News

Share

Connect with us

Stay Informed.

Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

445 News Items found
Lisa-Erika James, who participates in MSK's Visible Ink, is seen smiling.
The Creativity of People Facing Cancer: Visible Ink Writing Program at MSK

 Fast FactsOver 3,000 people diagnosed with cancer have participated in Visible Ink.The program is free and open to MSK patients of any ageTo join...
Q&A
Cardiologist Anthony Yu examines a patient
Staying Heart-Healthy during and after Cancer Treatment

Learn how MSK works to keep people with cancer heart healthy.
(From left) Jacy and Nikki on a recent trip to Paris
Celebrating Pride With Authentic Voices

Nikki Chotas, who uses the pronouns they/them, has dedicated much of their life to speaking up for and working to empower those who may feel helpless and without a voice. They attribute their pursuits in part to feeling voiceless in their younger years.
Rendering of a primary tumor mass with adjoining blood vessels (shown in red). Cells that have detached from the tumor and entered the bloodstream (shown as spheres) may circle back to the tumor and enhance its growth and aggressiveness.
Circulating Tumor Cells May Spur Cancer by a Previously Unknown Mechanism

A recent Memorial Sloan Kettering study shows that some circulating tumor cells can circle back and infiltrate their tumor of origin, enhancing its growth and aggressiveness.
Detail shot of a scientist handling samples
MSK Research Highlights, June 29, 2023

New MSK research discovered ferroptosis regulators that suggest therapeutic opportunities against hormone receptor-positive cancers; examined how tumor-associated macrophages might be turned against cancer; acquired new insights into joint inflammation in rheumatoid arthritis; developed a systems-level platform called epichaperomics to map changes in interactors among thousands of proteins involved in cancer-related processes; and investigated how artificial intelligence could help diagnose an invasive form of breast cancer.
In the Lab
Confocal microscopic image of mouse lymphedema tissue with staining for immune cells and lymphatic vessels.
Researchers Zero In on the Cause of Lymphedema, a Debilitating Cancer Complication

Learn how an MSK laboratory is bringing much-needed focus to cancer-related lymphedema and investigating new ways to prevent the complication.
Ask the Expert
Mom and daughter having conversation
10 Tips for Talking with Your Child about Cancer

Find tools for discussing a cancer diagnosis with your children.
Feature
DNA molecules wrapped around histones
The Future of Cancer Research: Five Reasons for Optimism

Discover some of the most exciting research that Memorial Sloan Kettering scientists are pursuing in the fight against cancer.
Pictured: Joan Massagué
Cancer Biologist Joan Massagué Honored on Two Continents

Joan Massagué, Chair of the Cancer Biology and Genetics Program in the Sloan Kettering Institute, has been named the recipient of two prestigious awards.
Garth Atchley
His Cancer Has Spread Three Times, but It’s Not Stopping Garth Atchley

When cancer cells change, special testing enables new therapies to keep the disease at bay. Garth Atchley was diagnosed with lung cancer that spread to his brain four years ago, and he’s still running marathons.